Free Trial
NASDAQ:SKIN

Beauty Health (SKIN) Stock Price, News & Analysis

Beauty Health logo
$1.67 0.00 (0.00%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$1.67 0.00 (0.00%)
As of 01/31/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Beauty Health Stock (NASDAQ:SKIN)

Key Stats

Today's Range
$1.62
$1.73
50-Day Range
$1.41
$1.90
52-Week Range
$0.91
$5.17
Volume
580,816 shs
Average Volume
486,564 shs
Market Capitalization
$207.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.55
Consensus Rating
Hold

Company Overview

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Beauty Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
41st Percentile Overall Score

SKIN MarketRank™: 

Beauty Health scored higher than 41% of companies evaluated by MarketBeat, and ranked 775th out of 957 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Beauty Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 3 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Beauty Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Beauty Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Beauty Health are expected to decrease in the coming year, from ($0.25) to ($0.30) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Beauty Health is -3.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Beauty Health is -3.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Beauty Health has a P/B Ratio of 3.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Beauty Health's valuation and earnings.
  • Percentage of Shares Shorted

    11.33% of the float of Beauty Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Beauty Health has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Beauty Health has recently increased by 6.46%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Beauty Health does not currently pay a dividend.

  • Dividend Growth

    Beauty Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.33% of the float of Beauty Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Beauty Health has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Beauty Health has recently increased by 6.46%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Beauty Health has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 18 news articles for Beauty Health this week, compared to 16 articles on an average week.
  • Search Interest

    1 people have searched for SKIN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Beauty Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,994.00 in company stock.

  • Percentage Held by Insiders

    41.00% of the stock of Beauty Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    93.26% of the stock of Beauty Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Beauty Health's insider trading history.
Receive SKIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beauty Health and its competitors with MarketBeat's FREE daily newsletter.

SKIN Stock News Headlines

Is this Elon’s true agenda?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them
The Beauty And Wellness Trends That Will Dominate 2025
See More Headlines

SKIN Stock Analysis - Frequently Asked Questions

Beauty Health's stock was trading at $1.59 on January 1st, 2025. Since then, SKIN stock has increased by 5.0% and is now trading at $1.67.
View the best growth stocks for 2025 here
.

The Beauty Health Company (NASDAQ:SKIN) released its quarterly earnings results on Thursday, May, 9th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.04. The business's revenue for the quarter was down 5.7% compared to the same quarter last year.

Top institutional investors of Beauty Health include 180 Wealth Advisors LLC (0.07%), Newman Dignan & Sheerar Inc. (0.06%) and SG Americas Securities LLC (0.03%). Insiders that own company stock include Michael P Monahan, Desiree Gruber and Doug K Schillinger.
View institutional ownership trends
.

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Beauty Health investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/09/2024
Today
1/31/2025
Next Earnings (Estimated)
3/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SKIN
Fax
N/A
Employees
1,030
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.55
High Stock Price Target
$5.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+52.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-100,120,000.00
Pretax Margin
-7.66%

Debt

Sales & Book Value

Annual Sales
$347.62 million
Book Value
$0.48 per share

Miscellaneous

Free Float
73,232,000
Market Cap
$207.28 million
Optionable
Optionable
Beta
0.81
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:SKIN) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners